India Glycols Intrinsic Value
India Glycols (INDIAGLYCO) median intrinsic value is ₹659.25 from 10 valuation models (range ₹250–₹791), vs current price ₹263.70 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit INDIAGLYCO share price screener.
INDIAGLYCO Valuation Methods Summary — DCF, Graham Number & P/E
India Glycols intrinsic value across 10 models vs current price ₹263.70 — upside/downside and value range per method. Check INDIAGLYCO market capitalization to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹791.10 | ₹632.88 - ₹949.32 | +200.0% | EPS: ₹54.56, Sector P/E: 25x |
| Book Value Method | asset | ₹659.25 | ₹593.33 - ₹725.18 | +150.0% | Book Value/Share: ₹862.65, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹527.40 | ₹474.66 - ₹580.14 | +100.0% | Revenue/Share: ₹1164.71, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹527.40 | ₹474.66 - ₹580.14 | +100.0% | EBITDA: ₹720.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹659.25 | ₹527.40 - ₹791.10 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹349.18 | ₹314.26 - ₹384.10 | +32.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹791.10 | ₹711.99 - ₹870.21 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹527.40 | ₹474.66 - ₹580.14 | +100.0% | ROE: 11.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹791.10 | ₹711.99 - ₹870.21 | +200.0% | EPS: ₹54.56, BVPS: ₹862.65 |
| Dividend Yield Method | dividend | ₹250.00 | ₹225.00 - ₹275.00 | -5.2% | DPS: ₹7.50, Target Yield: 3.0% |
INDIAGLYCO Intrinsic Value vs Market Price — All Valuation Models
India Glycols fair value range ₹250–₹791 vs current market price ₹263.70 across 10 valuation models. See INDIAGLYCO price to book ratio to compare market price against book value per share.
INDIAGLYCO Intrinsic Value Analysis — Undervalued or Overvalued?
India Glycols median intrinsic value ₹659.25, current price ₹263.70 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of INDIAGLYCO?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of India Glycols (INDIAGLYCO) is ₹659.25 (median value). With the current market price of ₹263.70, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹250.00 to ₹791.10, indicating ₹250.00 - ₹791.10.
Is INDIAGLYCO undervalued or overvalued?
Based on our multi-method analysis, India Glycols (INDIAGLYCO) appears to be trading below calculated value by approximately 150.0%.
INDIAGLYCO Financial Health — Key Ratios vs Industry Benchmarks
India Glycols financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.95 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 11.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.61x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INDIAGLYCO Cash Flow Quality — Operating & Free Cash Flow
India Glycols operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹769 Cr | ₹386 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹362 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹439 Cr | ₹187 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹326 Cr | ₹161 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹116 Cr | ₹116 Cr | Positive Free Cash Flow | 8/10 |